A platinated prodrug leveraging PROTAC technology for targeted protein degradation and enhanced antitumor efficacy
Year: 2025
Type: article
Source: Inorganic Chemistry Frontiers
DOI: 10.1039/d5qi00605h
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408787742
